UnitedHealth Group Incorporated (NYSE:UNH) had its target price raised by research analysts at Piper Jaffray Companies to $228.00 in a research report issued on Tuesday, The Fly reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Piper Jaffray Companies’ price objective would indicate a potential upside of 11.83% from the stock’s current price.

UNH has been the subject of several other reports. Barclays PLC increased their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research report on Wednesday, July 19th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Cowen and Company reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, July 14th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, BidaskClub cut UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $207.60.

Shares of UnitedHealth Group (NYSE:UNH) traded up 5.53% during mid-day trading on Tuesday, hitting $203.89. 8,949,715 shares of the company were exchanged. UnitedHealth Group has a 12-month low of $133.03 and a 12-month high of $206.62. The stock has a market cap of $197.13 billion, a PE ratio of 24.49 and a beta of 0.63. The stock’s 50-day moving average price is $196.56 and its 200 day moving average price is $184.87.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same period in the prior year, the business earned $2.17 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities analysts anticipate that UnitedHealth Group will post $9.87 EPS for the current fiscal year.

WARNING: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/10/17/piper-jaffray-companies-boosts-unitedhealth-group-incorporated-unh-price-target-to-228-00.html.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold 76,174 shares of company stock worth $14,981,909 in the last 90 days. Company insiders own 0.89% of the company’s stock.

Institutional investors have recently bought and sold shares of the stock. Schwab Charles Investment Management Inc. boosted its holdings in UnitedHealth Group by 5.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after acquiring an additional 183,401 shares during the last quarter. Suntrust Banks Inc. boosted its holdings in UnitedHealth Group by 8.5% in the first quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock valued at $42,774,000 after acquiring an additional 20,541 shares during the last quarter. Factory Mutual Insurance Co. boosted its holdings in UnitedHealth Group by 20.9% in the second quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after acquiring an additional 72,000 shares during the last quarter. Shell Asset Management Co. boosted its holdings in UnitedHealth Group by 0.8% in the second quarter. Shell Asset Management Co. now owns 157,241 shares of the healthcare conglomerate’s stock valued at $29,156,000 after acquiring an additional 1,254 shares during the last quarter. Finally, Moody Lynn & Lieberson LLC boosted its holdings in UnitedHealth Group by 569.9% in the second quarter. Moody Lynn & Lieberson LLC now owns 8,937 shares of the healthcare conglomerate’s stock valued at $1,657,000 after acquiring an additional 7,603 shares during the last quarter. Institutional investors and hedge funds own 86.11% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.